{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:53:13Z","timestamp":1791579193153,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["KSVGH115-148"],"award-info":[{"award-number":["KSVGH115-148"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["KSVGH115-D01-1"],"award-info":[{"award-number":["KSVGH115-D01-1"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjmed.2026.09.010","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:05:18Z","timestamp":1789427118000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prior GLP-1RA or tirzepatide use and early cardiorenal outcomes after metabolic and bariatric surgery"],"prefix":"10.1016","author":[{"given":"Ting-Chun","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-2233","authenticated-orcid":false,"given":"Renin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjmed.2026.09.010_bib0001","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.soard.2022.06.284","article-title":"American society for metabolic and bariatric surgery 2020 estimate of metabolic and bariatric procedures performed in the United States","volume":"18","author":"Clapp","year":"2022","journal-title":"Surg Obes Relat Dis J Am Soc Bariatr Surg"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.010_bib0002","article-title":"Metabolic and bariatric surgery utilization trends in the United States: evidence from 2012 to 2021 national electronic medical records network","volume":"4","author":"Alsuhibani","year":"2023","journal-title":"Ann Surg Open Perspect Surg Hist Educ Clin Approaches"},{"issue":"12","key":"10.1016\/j.amjmed.2026.09.010_bib0003","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American society for metabolic and bariatric surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg Obes Relat Dis J Am Soc Bariatr Surg"},{"issue":"20","key":"10.1016\/j.amjmed.2026.09.010_bib0004","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"issue":"10287","key":"10.1016\/j.amjmed.2026.09.010_bib0005","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(21)00591-2","article-title":"Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174\u2009772 participants","volume":"397","author":"Syn","year":"2021","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.amjmed.2026.09.010_bib0006","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.09.010_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.010_bib0008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2026.09.010_bib0009","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.amjmed.2026.09.010_bib0010","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.cgh.2024.10.003","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"23","author":"Kindel","year":"2025","journal-title":"Clin Gastroenterol Hepatol Clin Pr J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.010_bib0011","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11695-025-08436-w","article-title":"Preoperative GLP-1 receptor agonists exposure and risk of postoperative acute kidney injury after metabolic and bariatric surgery: a retrospective study","volume":"36","author":"Hung","year":"2026","journal-title":"Obes Surg"},{"issue":"7","key":"10.1016\/j.amjmed.2026.09.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.21016","article-title":"Neurodegeneration and stroke after semaglutide and tirzepatide in patients with diabetes and obesity","volume":"8","author":"Lin","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjmed.2026.09.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102777","article-title":"Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study","volume":"75","author":"Anson","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.amjmed.2026.09.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112279","article-title":"Clinical effectiveness of tirzepatide for patients with atrial fibrillation and type 2 diabetes: a retrospective cohort study","volume":"225","author":"Wu","year":"2025","journal-title":"Diabetes Res Clin Pr"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.010_bib0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12933-024-02364-2","article-title":"Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists","volume":"23","author":"Lai","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.010_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.amjmed.2026.09.010_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.010_bib0018","first-page":"24","article-title":"TriNetX and real-world evidence: a critical review of its strengths, limitations, and bias considerations in clinical research","volume":"1","author":"Nassar","year":"2025","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.amjmed.2026.09.010_bib0019","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","article-title":"Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients","volume":"9","author":"Taquet","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1016\/j.amjmed.2026.09.010_bib0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2026.09.010_bib0021","unstructured":"von Elm E , Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The STROBE reporting checklist. In: Harwood J, Albury C, de Beyer J, Schl\u00fcssel M, Collins G, eds. The EQUATOR Network Reporting Guideline Platform. The UK EQUATOR Centre. Accessed September 1, 2026. https:\/\/resources.equator-network.org\/reporting-guidelines\/strobe\/strobe-checklist.docx"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.010_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4803","article-title":"Association of preoperative body weight and weight loss with risk of death after bariatric surgery","volume":"3","author":"Sun","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.010_bib0023","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00268-021-06394-9","article-title":"Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations: a 2021 update","volume":"46","author":"Stenberg","year":"2022","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.010_bib0024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10456","key":"10.1016\/j.amjmed.2026.09.010_bib0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.010_bib0026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.09.010_bib0027","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.amjmed.2026.09.010_bib0028","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1111\/dom.15636","article-title":"Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists","volume":"26","author":"Klonoff","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.010_bib0029","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:37:06Z","timestamp":1791578226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326006741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S0002934326006741"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.09.010","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prior GLP-1RA or tirzepatide use and early cardiorenal outcomes after metabolic and bariatric surgery","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}